MedPath

CEDARS-SINAI MEDICAL CENTER

🇺🇸United States
Ownership
Private, Subsidiary
Established
1902-01-01
Employees
12K
Market Cap
-
Website
http://www.cedars-sinai.org

Lanreotide Levels in Acromegaly

Conditions
Acromegaly
Interventions
Other: Blood draw
First Posted Date
2009-06-10
Last Posted Date
2009-06-10
Lead Sponsor
Cedars-Sinai Medical Center
Registration Number
NCT00916916
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)

Not Applicable
Completed
Conditions
Acromegaly
Type 2 Diabetes Mellitus
Interventions
Diagnostic Test: Oral Glucose Tolerance Test
Diagnostic Test: Subcutaneous administration of recombinant human IGF-1
Diagnostic Test: Placebo
First Posted Date
2009-06-08
Last Posted Date
2019-07-09
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
28
Registration Number
NCT00915954
Locations
🇺🇸

Cedars-Sinai Medical Center Pituitary Center, Los Angeles, California, United States

CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction

Phase 1
Completed
Conditions
Recent Myocardial Infarction
Ventricular Dysfunction
Interventions
Biological: Autologous stem cell infusion
First Posted Date
2009-05-06
Last Posted Date
2014-02-12
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
31
Registration Number
NCT00893360
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

Adenosine Dual Source Computed Tomography (CT) Versus Adenosine Single Photon Emission Computed Tomography (SPECT)

Completed
Conditions
Coronary Artery Disease
First Posted Date
2009-05-04
Last Posted Date
2013-11-13
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
34
Registration Number
NCT00892307
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

Randomized Evaluation of Intracoronary Transplantation of Bone Marrow Stem Cells in Myocardial Infarction

Phase 1
Completed
Conditions
Myocardial Infarction
Interventions
Drug: Intracoronary Transplantation of Bone Marrow Stem Cells
First Posted Date
2009-04-02
Last Posted Date
2017-02-02
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
27
Registration Number
NCT00874354
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder

Phase 3
Terminated
Conditions
Anxiety Disorders
Interventions
First Posted Date
2009-02-04
Last Posted Date
2019-08-21
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
5
Registration Number
NCT00836069
Locations
🇺🇸

Cedars-Sinai Medical Center Department of Psychiatry and Behavioral Neurosciences, Los Angeles, California, United States

Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction

Active, not recruiting
Conditions
Cardiovascular Disease
First Posted Date
2009-01-30
Last Posted Date
2023-07-20
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
433
Registration Number
NCT00832702
Locations
🇺🇸

Cedars-Sinai Barbra Streisand Women's Heart Center, Los Angeles, California, United States

🇺🇸

University of Florida, Gainesville, Florida, United States

Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease

Not Applicable
Completed
Conditions
Inflammatory Bowel Disease
Crohn Disease
Ulcerative Colitis
Interventions
Biological: 23-valent polysaccharide pneumococcal vaccine (Pneumovax TM)
First Posted Date
2009-01-27
Last Posted Date
2009-01-27
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
69
Registration Number
NCT00829595
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

Measurement of Pituitary Volume and Hormonal Changes in Patients With Post-traumatic Stress Disorder

Completed
Conditions
Posttraumatic Stress Disorder
Interventions
Procedure: MRI of the pituitary
Procedure: DEX/CRH test
First Posted Date
2008-12-29
Last Posted Date
2015-02-04
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
39
Registration Number
NCT00815204
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

Allopurinol Maintenance Study for Bipolar Disorder

Phase 4
Terminated
Conditions
Bipolar Disorder
Mania
Mixed Mania
Interventions
First Posted Date
2008-08-11
Last Posted Date
2019-10-02
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
15
Registration Number
NCT00732251
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath